METHODS OF TREATING PTSD AND NEUROLOGICAL DISORDERS

IMIDAZOPIPERAZINE INHIBITORS OF TRANSCRIPTION ACTIVATING PROTEINS

METHODS OF TREATING ACUTE DEPRESSION AND ANXIETY

MASP-2 INHIBITORS AND METHODS OF USE

SIX-MEMBERED CYCLOTHIAZOLE COMPOUND AND USE THEREOF

NITROGEN-CONTAINING TETRACYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF

ADENOSINE RECEPTOR ANTAGONISTS

ORAL FILM FORMULATION FOR MODULATING ABSORPTION PROFILE

CERTAIN 2,5-DIAZABICYCLO[4.2.0]OCTANES AND OCTAHYDROFURO[3,4-B]PYRAZINES AS GLP-1 RECEPTOR MODULATORS

AROMATIC HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR AND USES THEREOF

SULFOXIMINE GLYCOSIDASE INHIBITORS

BIFUNCTIONAL ARYLSULPHONAMIDE COMPOUNDS

SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS

cGAS ANTAGONIST COMPOUNDS

BIPHENYL-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS

REGIMENS FOR TREATING HIV INFECTIONS AND AIDS

TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE

NOVEL ISOINDOLINONE DERIVATIVE COMPOUNDS AS CASPASE INHIBITORS

COMBINATION THERAPIES

STING AGONIST COMPOUNDS AND CONJUGATES

ORGANIC COMPOUNDS

SALT CRYSTAL FORM AND FREE BASE CRYSTAL FORM OF KINASE INHIBITOR

GEPOTIDACIN AND VANCOMYCIN FOR USE IN THE TREATMENT OF AN INFECTION CAUSED BY STAPHYLOCOCCUS SAPROPHYTICUS

TIP60 NEURO-EPIGENETIC MODULATORS

ORGANIC COMPOUNDS

PHARMACEUTICAL COMPOSITIONS

Sustained Release Pharmaceutical Composition of Upadacitinib

Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor

COMBINATION OF 8-CHLORO-N-(4-(TRIFLUOROMETHOXY)PHENYL)QUINOLIN-2-AMINE AND ITS DERIVATIVES WITH A JAK INHIBITOR

COMPOUNDS FOR USE IN TREATING NEUROLOGICAL DISORDERS

2-(INDAZOL-5-YL)-6-(PIPERIDIN-4-YL)-1,7-NAPHTHYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES

1-AMINOBENZO[4,5]IMIDAZO[1,2-A]PYRAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION THEREFOR AND USE THEREOF

SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS

CXCR7 INHIBITORS FOR THE TREATMENT OF CANCER

Phosphodiesterase-5 Inhibitor Combinations, Methods of Making, and Methods of Use Thereof

Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate

BTK INHIBITORS

FUSED RING-SUBSTITUTED SIX-MEMBERED HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

COMPOSITIONS AND METHODS FOR ENHANCING KRAS INHIBITOR OR SHP2 INHIBITOR EFFICACY

COMPOUNDS AND METHODS FOR MODULATING SPLICING

SLEEP IMPROVING AGENT

ANTIPROLIFERATIVE COMPOUNDS AND SECOND ACTIVE AGENTS FOR COMBINED USE

PYRAZOLE DERIVATIVES AS STING AGONISTS

MACROCYCLIC BTK INHIBITORS

INHIBITORS OF SARS-COV-2

TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS

HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME

DNA POLYMERASE THETA INHIBITOR AND USE THEREOF

CYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

BENZOTHIAZOLE, BENZOISOXAZOLE, AND BENZODIOXOLE ANALOGS AS RXFP1 RECEPTOR AGONISTS

HETEROCYCLIC COMPOUNDS AS DYRK1A INHIBITORS

BACTERIAL COMPOSITIONS AND METHODS FOR TREATING CANCER AND IMMUNE DISEASES

USES OF DPP IV INHIBITORS

CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION THERAPY

FUSED RING COMPOUND ACTING AS SHP2 INHIBITOR

ARYLSULPHONAMIDE COMPOUNDS

BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS

Pharmaceutical Compounds and Compositions as C-Kit Kinase Inhibitors

COMPOUNDS AND METHODS FOR MODULATING STAT3

Intestine-Targeted Drug Delivery Compositions and Preparation Methods Thereof

POLYMORPH OF KRAS INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF

PARP INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF

TREATMENT OF NEUROLOGICAL DISORDERS

METHODS OF TREATING ALOPECIA ARAETA

POLYMORPH FORMS OF A 5H-PYRROLO[2,3-b]PYRAZINE DERIVATIVE, METHODS OF PREPARATION, AND USES THEREFORE

HETEROCYCLIC SUBSTITUTED 1,3,4-THIADIAZOLE AND PYRIDAZINE COMPOUNDS AND METHODS OF USING THE SAME

SOS1 Inhibitor With Pyrido-Fused Six-Membered Ring Structure

Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors

BRUTON'S TYROSINE KINASE INHIBITORS AS ANTIVIRAL AGENTS

Synergistic compositions for use in the treatment of cancer

AN IGF1R INHIBITOR AND AN AKT INHIBITOR FOR USE IN THE TREATMENT OF CANCER

REGULATING T CELL IMMUNE RESPONSE THROUGH IGF-I RECEPTOR (IGF-1R)

SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF

NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE PARP INHIBITOR AND USE THEREOF

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

BTK INHIBITORS

Compounds and Compositions as C-Kit Kinase Inhibitors

WRN INHIBITORS

COMPOSITIONS AND METHODS FOR TREATING WITH A COMBINATION OF ALTERNATING ELECTRIC FIELDS AND DNA-DEPENDENT PROTEIN KINASE INHIBITORS

TREATMENT OF HIDRADENITIS WITH JAK INHIBITORS

APPLICATION OF IMIDAZO [1,2-A] PYRAZINE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS IN THE PREPARATION OF ANTI-CORONAVIRUS DRUGS

THERAPEUTIC TARGETS AND AGENTS FOR THE TREATMENT OF POSTTRAUMATIC STRESS DISORDER

N-(5-SUBSTITUTED-[(1,3,4-THIADIAZOLYL) OR (THIAZOLYL)])(SUBSTITUTED)CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR INHIBITING HUMAN POLYMERASE THETA

METHODS FOR TREATING ALZHEIMER DISEASE AND FOR REDUCING AMYLOID BETA FORMATION

TREATMENT OF NEURODEGENERATIVE DISEASES VIA ADMINISTRATION OF BUNTANETAP AND A PHOSPHODIESTERASE INHIBITOR

COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

Antiviral Therapy

PHARMACEUTICAL COMPOSITIONS

PHARMACEUTICAL COMPOSITIONS

PYRAZOLO FUSED RING COMPOUND AND USE THEREOF

HPK1 ANTAGONISTS AND USES THEREOF

Imidazo[1,2- a]pyrazine and Imidazo[1,2- a]pyridine Based Tyrosyl-DNA Phosphodiesterase I (TDP1) Inhibitors

NOVEL COMPOSITIONS AND METHODS

6-SUBSTITUTED INDOLE COMPOUNDS

NITROGEN-CONTAINING COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

USE OF GCN2 INHIBITORS IN TREATING CANCER

COMBINATION THERAPIES FOR HIV INFECTIONS AND USES THEREOF

PARG INHIBITORY COMPOUNDS

HETEROARYL COMPOUNDS USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS

NITROGEN-CONTAINING TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF

TETRAHYDRONAPTHYRIDINE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD

METHOD OF INJECTING DIHYDROERGOTAMINE INTO THE BODY

NOVEL METHODS

CONTINUOUS DELIVERY PREPARATION CAPABLE OF BEING STABLY RELEASED AND PREPARATION METHOD THEREFOR

BENZOPIPERAZINE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD

Solid Forms of Upadacitinib

NK3 modulators and uses thereof

SUBSTITUTED TRIAZOLOHETEROARYL COMPOUNDS AS USP1 INHIBITORS AND THE USE THEREOF

COMPOUNDS AND METHODS FOR MODULATING SPLICING

NOVEL ENTEROCOCCUS FAECIUM LCM001 STRAIN, AND USE THEREOF

COMPOSITIONS FOR ENHANCING SEXUAL PLEASURE WITH REDUCED PHARMACEUTICAL LOAD OF PDE5 INHIBITOR

HETEROARYL DERIVATIVE PARP INHIBITOR AND USE THEREOF

COMPOUNDS AND METHODS FOR MODULATING SPLICING

Compounds, Compositions and Methods for Attenuation of Mammalian Translation of C-MYC or N-MYC Proteins of the MYC Proto-Oncogene Family of BHLH Transcription Factors

NOVEL NANOPARTICLES OF ANTIRETROVIRAL DRUGS, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRAL INFECTIONS

THERAPEUTIC AGENT COMPOSITION AND METHOD OF USE, FOR TREATING, RELIEVING, OR ALLEVIATING ALZHEIMER'S DISEASE

HETEROARYL HETEROCYCLIC COMPOUNDS AND USES THEREOF

TREATING SPONDYLOARTHRITIC CONDITIONS WITH UPADACITINIB

METHODS OF TREATING RBP4 RELATED DISEASES WITH TRIAZOLOPYRIDINES

TREATMENT OF SCLERODERMA AND RAYNAUD'S SYNDROME

INHIBITORS OF THE MTDH-SND1 PROTEIN COMPLEX FOR CANCER THERAPY

Combination methods and compositions including sleep therapeutics for treating mood

BICYCLIC DERIVATIVE PARP INHIBITOR AND USE THEREOF

TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS

METHIONINE ADENOSYLTRANSFERASE 2A INHIBITOR FOR TREATING MTAP DELETION-TYPE CANCER

Substituted Quinoxalines

CHIMERIC MODIFIED ION CHANNELS AND USES THEREOF FOR TREATMENT OF TRIGEMINAL NERVE DISORDERS

PHOSPHORYLATED TRISTETRAPROLIN AS A BIOMARKER AND THERAPEUTIC TARGET FOR ANTIAGING DRUGS

INHIBITOR OF BTK AND MUTANTS THEREOF

METHODS OF TREATING VITILIGO WITH UPADACITINIB

IRHOM2 INHIBITORS AND USES THEREOF

THIOPHENE RING COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

AZAINDAZOLE MACROCYCLE COMPOUNDS AND USES THEREOF

5-SUBSTITUTED PYRIDINE-2(1H)-KETONE COMPOUND AND USE THEREOF

SUBSTITUTED HYDANTOIN COMPOUNDS, METHODS FOR PREPARATION THEREOF AND USE THEREOF IN THE TREATMENT AND/OR PREVENTION OF A CORONA VIRUS DISEASE

SMARCA DEGRADERS AND USES THEREOF

PRMT5 INHIBITOR AND THE USE THEREOF

KRAS G12D INHIBITORS AND USES THEREOF

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

PRMT5 INHIBITORS AND USES THEREOF

ISOXAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERED RELATED THERETO

PHENYL ACETAMIDE BASED IL-17A MODULATORS AND USES THEREOF

A PHARMACEUTICAL COMPOSITION COMPRISING COMBINATION OF SITAGLIPTIN AND EMPAGLIFLOZIN

NOVEL METHODS

METHODS AND COMPOSITIONS FOR TREATING CANCER

ENGAGING THE CERVICAL SPINAL CORD CIRCUITRY TO RE-ENABLE VOLITIONAL CONTROL OF HAND FUNCTION IN TETRAPLEGIC SUBJECTS

Pharmaceutical Composition Comprising Lumateperone

Positive allosteric modulators of the muscarinic acetylcholine receptor M4

SUBSTITUTED TRICYCLIC COMPOUNDS AS PARP INHIBITORS AND USE THEREOF

NAD-AUGMENTATION THERAPY FOR PARKINSON'S DISEASE

TREATMENT OF RAYNAUD'S DISEASE

ORAL SOLID DOSE FORMULATIONS

AROYL SUBSTITUTED TRICYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

METHOD OF REDUCING PULMONARY EXACERBATIONS IN RESPIRATORY DISEASE PATIENTS

METHODS OF TREATING PAIN

TREATMENT OF SCLERODERMA

NOVEL PARP7 INHIBITOR AND USE THEREOF

UREA COMPOUND CONTAINING 2-HETEROAROMATIC RING SUBSTITUTION, PREPARATION METHOD THEREFOR AND USE THEREOF

Regimens for treating HIV infections and aids

PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELLULAR PROLIFERATION

COMPOUNDS FOR PREVENTING, INHIBITING, OR TREATING CANCER, AIDS AND/OR PREMATURE AGING

SMALL MOLECULE INHIBITORS FOR ANTI-CANCER COMBINATION THERAPY

NANOPARTICLES AND USES THEREOF FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS

PARP INHIBITOR CONTAINING PIPERAZINE STRUCTURE, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF

MITOFUSIN ACTIVATORS AND USES THEREOF

Further Substituted Triazolo Quinoxaline Derivatives

FACTOR XIIA INHIBITORS

SIRT6 ACTIVATORS

NOVEL INHIBITORS OF AUTOTAXIN

THERAPEUTIC TARGETING OF GPR68 TO INDUCE FERROPTOSIS

ORAL COMPLEX TABLET COMPRISING SITAGLIPTIN, DAPAGLIFLOZIN, AND METFORMIN

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS

SALTS AND SOLID FORMS OF A COMPOUND HAVING APJ RECEPTOR ACTIVITY

INHIBITORS OF BRUTON'S TYROSINE KINASE

HYDROISOQUINOLINE OR HYDRONAPHTHYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE

PYRAZOLYL DERIVATIVES AS INHIBITORS OF THE KRAS MUTANT PROTEIN

Inhibitors of RNA helicase DHX9 and uses thereof

METHODS OF TREATING PEDIATRIC PATIENTS WITH UPADACITINIB

PROCESS FOR THE PREPARATION OF SITAGLIPTIN FREE FROM GENOTOXIC IMPURITIES

EXTENDED RELEASE UPADACITINIB FORMULATIONS

Chemokine CXCR4 Receptor Modulators and Uses Related Thereto

SMALL MOLECULE MODULATORS OF FERROPTOSIS

PHARMACEUTICAL COMPOSITIONS COMPRISING ACALABRUTINIB

NOVEL BICYCLIC COMPOUNDS

HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE

DRAK2 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Pharmaceutical compositions

NOVEL METHODS

MODULATORS OF THE INTEGRATED STRESS PATHWAY

AGENT FOR USE IN THE TREATMENT OF GLIOMA

REHYDRATION COMPOSITION AND METHOD OF USE

Liquid oral formulations for tadalafil

APPLICATION OF COMPOUND IN PREPARATION OF DRUG FOR TREATING MYELOFIBROSIS AND RELATED SYMPTOMS/SIGNS THEREOF, AND USE OF COMPOUND

PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION COMPRISING GLUCOKINASE ACTIVATOR AND DPP-IV INHIBITOR, AND PREPARATION METHOD AND USE THEREOF

MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

HETEROCYCLIC LACTAM COMPOUND, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF

PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES

PHARMACEUTICAL COMPOSITION

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINES

HIGH ACTIVITY STING PROTEIN AGONIST

FUSED HETEROCYCLIC DERIVATIVES

Intratumoral Alpha-Emitter Radiation in Combination with Immune Checkpoint Regulators

MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV

Oral gliptin compositions and method for preparation thereof

PHARMACEUTICAL COMPOSITIONS OF LUMATEPERONE

Heterocyclic derivatives useful as SHP2 inhibitors

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING COMPOUNDS FOR TREATING CHOROIDAL VASCULAR DISEASES AND METHODS OF THEIR USE

POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY

FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS

NOVEL SALTS AND CRYSTALS

FUSED HETEROCYCLIC DERIVATIVES

DOSAGE REGIMENS FOR ECUBECTEDIN

Integrase Inhibitor and Use Thereof

HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS

COMPOUNDS FOR FGFRS INHIBITORS

GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY

COMPOSITIONS AND METHODS FOR ISLET CELL TRANSPLANTS

PRMT5 inhibiting compounds and uses thereof

SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF

Wild type kit inhibitors

PKC-Theta Modulators

GENE EDITING THERAPY FOR HIV INFECTION VIA DUAL TARGETING OF HIV GENOME AND CCR5

FUSED ISOXAZOLYL COMPOUNDS AS KAT6A INHIBITORS

COMPOUNDS TARGETING RNA-BINDING PROTEINS OR RNA-MODIFYING PROTEINS

AGELASTATIN A DERIVATIVES AND RELATED METHODS

NOVEL HETEROCYCLIC COMPOUNDS, COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF

NOVEL METHODS

Combination Therapies Comprising Kras Inhibitors and SPH2 Inhibitors

REPEATED ADMINISTRATION OF DIHYDROERGOTAMINE FOR TREATMENT OF FREQUENT MIGRAINE HEADACHES

MACROCYCLIC LRRK2 KINASE INHIBITORS

HETEROCYCLIC JAK INHIBITOR

HETEROCYCLIC DERIVATIVES AS CAMKK2 INHIBITORS

SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT

SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF

TREATMENT OF NEURODEGENERATIVE DISEASE USING CSA- AND INDY-TYPE COMPOUNDS

ADENOSINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

Liquid oral formulations for sildenafil

LIQUID ORAL FORMULATIONS FOR TADALAFIL

PHOSPHODIESTERASE-5 INHIBITOR COMBINATIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF

HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS

NOVEL METHODS

INTRAVAGINAL RING DEVICES

5-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE T

COMPOSITIONS FOR USE IN THE PREVENTION AND/ OR TREATMENT OF INTELLECTUAL DISABILITY AND NEURODEGENERATIVE DISEASES IN A SUBJECT WITH DOWN SYNDROME

POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE

COMBINATION THERAPY FOR PULMONARY HYPERTENSION

RIPK1 INHIBITORS AND METHODS OF USE

IMIDAZOLE-CONTAINING CONDENSED RING DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE

Pyrrolo[2, 3-b]Pyrazine-Based Bifunctional Compounds as HPK1 Degraders and the Use Thereof

METHIONINE ADENOSYLTRANSFERASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

METHODS OF CANCER TREATMENT USING A COMBINATION OF BTK INHIBITORS AND PI3 KINASE INHIBITORS

Precision Medicine Approach to Treating Parkinson's Disease with a Monoamine Oxidase Inhibitor, an Antioxidant, or Both

SOFT CHEWABLE FORMULATIONS WITH ACTIVE INGREDIENTS

INDOLINE DERIVATIVES AS DDRS INHIBITORS

PCSK9 INHIBITORS AND METHODS OF USE THEREOF

COMBINATION OF BITTER RECEPTOR AGONIST AND GUT-SIGNALING COMPOUND

FORMULATIONS AND METHODS FOR TREATING ERECTILE DYSFUNCTION

BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment

Pharmaceutical capsules comprising lumateperone mono-tosylate

TREATING SPONDYLOARTHRITIC AND PSORIATIC CONDITIONS WITH UPADACITINIB

POLYCYCLIC COMPOUND AND APPLICATION THEREOF

COMBINATION TREATMENT METHODS OF MULTIPLE SCLEROSIS

Five- and six-membered compound, and preparation method therefor and pharmaceutical composition and use thereof

NOVEL COMPOUNDS AND METHODS

SUBSTITUTED HYDANTOIN COMPOUNDS, METHODS FOR PREPARATION THEREOF AND USE THEREOF IN THE TREATMENT AND/OR PREVENTION OF A CORONA VIRUS DISEASE

METAP-2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS THEREOF

COMBINATION THERAPIES INCLUDING MYT1 INHIBITORS

TREATMENT OF AUTISM SPECTRUM DISORDERS, OBSESSIVE-COMPULSIVE DISORDER AND ANXIETY DISORDERS

NOVEL METHODS

Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide

CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF

TYK2 INHIBITORS AND USES THEREOF

KRAS INHIBITORS

Inhibitors of receptor interacting protein kinase I for the treatment of disease

TREATING SEX STEROID DEPENDENT CANCER WITH BMX INHIBITORS

Therapeutic Combinations of a CD19 Inhibitor and a BTK Inhibitor

COMPOUND USED AS SHP2 INHIBITOR AND USE THEREOF

Bruton's Tyrosine Kinase (BTK) INHIBITOR AND APPLICATION THEREOF

HIGHLY ACTIVE STING PROTEIN AGONIST COMPOUND

TYK2 INHIBITORS AND USES THEREOF

ANTIBACTERIAL COMPOUNDS

HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE

COMPOUNDS FOR THE ACTIVATION OF AMPK

Anti-cancer nuclear hormone receptor-targeting compounds

BCL-2 INHIBITORS

THE THERAPEUTIC REGIMEN

Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor

INJECTABLE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF

METHODS OF USING EHMT2 INHIBITORS IN TREATING OR PREVENTING BLOOD DISORDERS

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

DRY EYE TREATMENTS

PRESERVATIVE REMOVAL FROM EYE DROPS

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

Novel Crystalline Form Of 1-(8-Bromopyrido[2,3-E][1,2,4]triazolo[4,3-A]pyrazin-4-Yl)-Nmethylazetidin-3-Amine Hydrogen Sulfate Monohydrate